Mohammed Afshar
Direttore/Membro del Consiglio presso GENOMIC VISION
Profilo
Mohammed Afshar is the founder of Ariana Pharmaceuticals SA, where he holds the title of Chief Executive Officer & Director starting in 2009.
He is also the founder of RiboTargets Ltd.
Dr. Afshar's current job is as a Member-Supervisory Board at Génomic Vision SA, starting in 2022.
His former job was as a Research Fellow at The University of York.
Dr. Afshar's education includes undergraduate, graduate, and doctorate degrees from Université de Montpellier.
Posizioni attive di Mohammed Afshar
| Società | Posizione | Inizio |
|---|---|---|
| GENOMIC VISION | Direttore/Membro del Consiglio | 11/07/2022 |
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Fondatore | 01/01/2003 |
Precedenti posizioni note di Mohammed Afshar
| Società | Posizione | Fine |
|---|---|---|
| The University of York | Direttore Tecnico/Scientifico/R&S | - |
| RiboTargets Ltd. | Fondatore | - |
Formazione di Mohammed Afshar
| Université de Montpellier | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENOMIC VISION | Health Technology |
| Aziende private | 2 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
| RiboTargets Ltd. | Health Technology |
- Borsa valori
- Insiders
- Mohammed Afshar
